Therefore, changes in body fat distribution resulting from declining levels of estrogen, relatively higher androgen levels and greater distribution of hormone receptors can lead to increased risk of NAFLD in post-menopausal women16,26,28. Here, NR4A1 is linked to metabolic dysfunction-associated steatotic liver disease.